comprehensive -WSS

comprehensive

author：focus 2025-09-28 13:26:03 - browse：46942

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Maui wildfire now ranks as the fifth

WSS

Surge in Apellis stock fueled by confidence in safety of its eye drug

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Surge in Apellis stock fueled by confidence in safety of its eye drug

Illumina slashes 2023 revenue projections yet again

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Treatments for cramps don't cut it. Why aren't there better options?

focus

comprehensive

hotspot

Drug repurposing or repositioning? The language matters

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Heart attack and stroke risk calculators need revising

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Duchenne breakthrough therapy leaves behind pioneering families

Timeline: How the deadly wildfires took over Maui day by day

Hollywood unions extend contract negotiations for actors

Greece's new parliament sworn in following conservative party's election victory

Wildfire smoke exposes gaps in outdoor worker protections

Health AI: on the border between health care and tech

Wikipedia

Timeline: How the deadly wildfires took over Maui day by day

3 killed, 8 injured in late

10 states plan to sue EPA over standards for residential wood

NASA releases new images of 'fingerprint

Illinois Supreme Court finds assault weapons ban constitutional

Dozens dead from Maui wildfires: What we know about the victims

focus

hotspot

knowledge

leisure time